Dr Rollison earned her undergraduate degree in Biology from the University of Miami in 1997 and completed her master's (1999), PhD (2002) and postdoctoral training (2002-2004) in Cancer Epidemiology at the Johns Hopkins University. Dr Rollison joined Moffitt Cancer Center in 2004 as an Assistant Member in the Cancer Epidemiology Program. She was promoted to Associate Professor with tenure in 2010, and became a Senior Member in 2017. Dr Rollison’s primary research focuses on the potential role of viral infections in cancer etiology and the epidemiology of myelodysplastic syndromes. Dr Rollison also serves as Vice President and Chief Data Officer at Moffitt Cancer Center, bridging analytics strategies across research, clinical and operational areas of the organization. Since assuming this position in 2010, Dr Rollison has steered the evolution of its scope of responsibilities in three key areas: 1) leadership of the Office of Health Data Services, including four departments dedicated to providing access to high-quality patient data: Cancer Registry, Information Shared Services, Data Quality and Business Intelligence, and Health and Research Informatics (HRI); 2) executive visioning for Moffitt’s enterprise wide data warehouse and analytics strategy to support translational research, clinical pathways, accountable care analytics, and the practice of personalized medicine; and 3) service as co-Principal Investigator of the Total Cancer Care® protocol, the foundation of the Oncology Research Information Exchange Network (ORIEN). Dr Rollison was appointed to be Moffitt’s first Associate Center Director of Data Science in 2017, overseeing the academic departments of Integrated Mathematical Oncology and Biostatistics and Bioinformatics, as well as three data-related research Cores: Cancer Informatics, Biostatistics and Collaborative Data Services. In her role as ACD, Dr. Rollison seeks to promote the development of novel analytic approaches for the optimization of Moffitt’s extensive data assets, including unstructured data in the electronic medical record that can be used in mathematical models of cancer treatment response. Dr Rollison has authored more than 85 publications in peer-reviewed journals and currently serves as the Principal Investigator of a $2 million grant from the U.S. National Cancer Institute. Dr Rollison is a member of the American Association for Cancer Research, the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH) and the International Papillomavirus Society. She has been invited to speak on topics related to both cancer epidemiology and data science, presenting in national and international venues including Barcelona, Spain; Manduria, Italy; Berlin, Germany; and Lisbon, Portugal.
Abstracts this author is presenting: